Stubbs RJ - Search Results

1

Animal safety and toxicology of simvastatin and related hydroxy-methylglutaryl-coenzyme A reductase inhibitors.

Gerson RJ, MacDonald JS, Alberts AW, Kornbrust DJ, Majka JA, Stubbs RJ, Bokelman DL. Gerson RJ, et al. Among authors: stubbs rj. Am J Med. 1989 Oct 16;87(4A):28S-38S. doi: 10.1016/s0002-9343(89)80596-0. Am J Med. 1989. PMID: 2679082 Review.

2

Toxicity of the HMG-coenzyme A reductase inhibitor, lovastatin, to rabbits.

Kornbrust DJ, MacDonald JS, Peter CP, Duchai DM, Stubbs RJ, Germershausen JI, Alberts AW. Kornbrust DJ, et al. Among authors: stubbs rj. J Pharmacol Exp Ther. 1989 Feb;248(2):498-505. J Pharmacol Exp Ther. 1989. PMID: 2918466

3

Myopathy associated with HMG-CoA reductase inhibitors (HMGRIs) and cyclosporin A: evaluation in a rat model.

Smith PF, Eydelloth RS, Grossman SJ, Stubbs RJ, Schwartz MS, Germershausen JI, MacDonald JS. Smith PF, et al. Among authors: stubbs rj. Eur Heart J. 1992 Jul;13 Suppl B:2-6. doi: 10.1093/eurheartj/13.suppl_b.2. Eur Heart J. 1992. PMID: 1644096 No abstract available.

4

HMG-CoA reductase inhibitor-induced myopathy in the rat: cyclosporine A interaction and mechanism studies.

Smith PF, Eydelloth RS, Grossman SJ, Stubbs RJ, Schwartz MS, Germershausen JI, Vyas KP, Kari PH, MacDonald JS. Smith PF, et al. Among authors: stubbs rj. J Pharmacol Exp Ther. 1991 Jun;257(3):1225-35. J Pharmacol Exp Ther. 1991. PMID: 1904494

5

Enhancement of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitor efficacy through administration of a controlled-porosity osmotic pump dosage form.

McClelland GA, Stubbs RJ, Fix JA, Pogany SA, Zentner GM. McClelland GA, et al. Among authors: stubbs rj. Pharm Res. 1991 Jul;8(7):873-6. doi: 10.1023/a:1015899328105. Pharm Res. 1991. PMID: 1924137

6

Functional neurotoxicity evaluation of noribogaine using video-EEG in cynomolgus monkeys.

Authier S, Accardi MV, Paquette D, Pouliot M, Arezzo J, Stubbs RJ, Gerson RJ, Friedhoff LT, Weis H. Authier S, et al. Among authors: stubbs rj. J Pharmacol Toxicol Methods. 2016 Sep-Oct;81:306-12. doi: 10.1016/j.vascn.2016.04.012. Epub 2016 Apr 25. J Pharmacol Toxicol Methods. 2016. PMID: 27126304 Free article.

7

The physiological disposition of lovastatin.

Duggan DE, Chen IW, Bayne WF, Halpin RA, Duncan CA, Schwartz MS, Stubbs RJ, Vickers S. Duggan DE, et al. Among authors: stubbs rj. Drug Metab Dispos. 1989 Mar-Apr;17(2):166-73. Drug Metab Dispos. 1989. PMID: 2565206

8

Single-dose pharmacokinetics of 14C-lovastatin in chronic renal failure.

Quérin S, Lambert R, Cusson JR, Grégoire S, Vickers S, Stubbs RJ, Sweany AE, Larochelle P. Quérin S, et al. Among authors: stubbs rj. Clin Pharmacol Ther. 1991 Oct;50(4):437-41. doi: 10.1038/clpt.1991.161. Clin Pharmacol Ther. 1991. PMID: 1914380

9

Determination of mevinolin and mevinolinic acid in plasma and bile by reversed-phase high-performance liquid chromatography.

Stubbs RJ, Schwartz M, Bayne WF. Stubbs RJ, et al. J Chromatogr. 1986 Dec 19;383(2):438-43. doi: 10.1016/s0378-4347(00)83492-1. J Chromatogr. 1986. PMID: 3644824 No abstract available.

10

Determination of ivermectin in human plasma and milk by high-performance liquid chromatography with fluorescence detection.

Chiou R, Stubbs RJ, Bayne WF. Chiou R, et al. Among authors: stubbs rj. J Chromatogr. 1987 Apr 24;416(1):196-202. doi: 10.1016/0378-4347(87)80502-9. J Chromatogr. 1987. PMID: 3597637 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

160 results

Search Page

Filters